Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemiaSofie Peirs, Pieter Van Vlierberghe, Tim Pieters et al.|Leukemia|2017Cited by 70
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Pieter Van Vlierberghe, Sofie Peirs et al.|Haematologica|2018Cited by 32